Apparent Reduction of ADAM10 in Scrapie-Infected Cultured Cells and in the Brains of Scrapie-Infected Rodents

Molecular Neurobiology

Volumn 50, Issue 3, 2014, Pages 875-887

  Chen, Cao ^a,b   Lv, Yan ^a,b   Zhang, Bao Yun ^a,b   Zhang, Jin ^a,b   Shi, Qi ^a,b   Wang, Jing ^a,b   Tian, Chan ^a,b   Gao, Chen ^a,b   Xiao, Kang ^a,b   Ren, Ke ^a,b   Zhou, Wei ^a,b   Dong, Xiao Ping ^a,b,c  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

ADAM10; Interaction; Prion diseases; PrPC; SMB cell

Indexed keywords

ADAM PROTEIN; ADAM10 PROTEIN, MOUSE; MEMBRANE PROTEIN; PRION PROTEIN; SECRETASE;

ANIMAL; BRAIN; CELL LINE; GENETICS; HAMSTER; METABOLISM; MOUSE; PATHOLOGY; SCRAPIE;

ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; BRAIN; CELL LINE; CRICETINAE; MEMBRANE PROTEINS; MICE; PRPSC PROTEINS; SCRAPIE;

EID: 84936763789     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-014-8708-7     Document Type: Article

References (43)

1. Aguzzi A, Calella AM (2009) Prions: protein aggregation and infectious diseases. Physiol Rev 89(4):1105–1152
2. Prusiner SB (1998) Prions. Proc Natl Acad Sci U S A 95(23):13363–13383
3. Taylor DR, Hooper NM (2006) The prion protein and lipid rafts. Mol Membr Biol 23(1):89–99
4. Taylor DR, Parkin ET, Cocklin SL, Ault JR, Ashcroft AE, Turner AJ, Hooper NM (2009) Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein. J Biol Chem 284(34):22590–22600
5. Chen SG, Teplow DB, Parchi P, Teller JK, Gambetti P, Autilio-Gambetti L (1995) Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem 270(32):19173–19180
6. Harris DA, Huber MT, van Dijken P, Shyng SL, Chait BT, Wang R (1993) Processing of a cellular prion protein: identification of N- and C-terminal cleavage sites. Biochemistry 32(4):1009–1016
7. Jimenez-Huete A, Lievens PM, Vidal R, Piccardo P, Ghetti B, Tagliavini F, Frangione B, Prelli F (1998) Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Am J Pathol 153(5):1561–1572
8. Vincent B, Paitel E, Saftig P, Frobert Y, Hartmann D, De Strooper B, Grassi J, Lopez-Perez E, Checler F (2001) The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem 276(41):37743–37746
9. Mange A, Beranger F, Peoc’h K, Onodera T, Frobert Y, Lehmann S (2004) Alpha- and beta- cleavages of the amino-terminus of the cellular prion protein. Biol Cell 96(2):125–132
10. Caughey B, Raymond GJ, Ernst D, Race RE (1991) N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease (s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol 65(12):6597–6603
11. Yadavalli R, Guttmann RP, Seward T, Centers AP, Williamson RA, Telling GC (2004) Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation. J Biol Chem 279(21):21948–21956
12. Owen JP, Rees HC, Maddison BC, Terry LA, Thorne L, Jackman R, Whitelam GC, Gough KC (2007) Molecular profiling of ovine prion diseases by using thermolysin-resistant PrPSc and endogenous C2 PrP fragments. J Virol 81(19):10532–10539
13. Cisse MA, Sunyach C, Lefranc-Jullien S, Postina R, Vincent B, Checler F (2005) The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity. J Biol Chem 280(49):40624–40631
14. Hooper NM (2005) Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein. Biochem Soc Trans 33(Pt 2):335–338
15. Yamamoto S, Higuchi Y, Yoshiyama K, Shimizu E, Kataoka M, Hijiya N, Matsuura K (1999) ADAM family proteins in the immune system. Immunol Today 20(6):278–284
16. White JM (2003) ADAMs: modulators of cell-cell and cell-matrix interactions. Curr Opin Cell Biol 15(5):598–606
17. Novak U (2004) ADAM proteins in the brain. J Clin Neurosci 11(3):227–235
18. Huovila AP, Turner AJ, Pelto-Huikko M, Karkkainen I, Ortiz RM (2005) Shedding light on ADAM metalloproteinases. Trends Biochem Sci 30(7):413–422
19. Yang P, Baker KA, Hagg T (2006) The ADAMs family: coordinators of nervous system development, plasticity and repair. Prog Neurobiol 79(2):73–94
20. Edwards DR, Handsley MM, Pennington CJ (2008) The ADAM metalloproteinases. Mol Aspects Med 29(5):258–289
21. Murphy G (2008) The ADAMs: signalling scissors in the tumour microenvironment. Nat Rev Cancer 8(12):929–941
22. Benarroch EE (2012) ADAM proteins, their ligands, and clinical implications. Neurology 78(12):914–920
23. Altmeppen HC, Puig B, Dohler F, Thurm DK, Falker C, Krasemann S, Glatzel M (2012) Proteolytic processing of the prion protein in health and disease. Am J Neurodegener Dis 1(1):15–31
24. Dong CF, Wang XF, Wang X, Shi S, Wang GR, Shan B, An R, Li XL, Zhang BY, Han J, Dong XP (2008) Molecular interaction between prion protein and GFAP both in native and recombinant forms in vitro. Med Microbiol Immunol 197(4):361–368
25. Haig DA, Clarke MC (1971) Multiplication of the scrapie agent. Nature 234(5324):106–107
26. Chen JM, Gao C, Shi Q, Shan B, Lei YJ, Dong CF, An R, Wang GR, Zhang BY, Han J, Dong XP (2008) Different expression patterns of CK2 subunits in the brains of experimental animals and patients with transmissible spongiform encephalopathies. Arch Virol 153(6):1013–1020
27. Shi Q, Zhang BY, Gao C, Zhang J, Jiang HY, Chen C, Han J, Dong XP (2012) Mouse-adapted scrapie strains 139A and ME7 overcome species barrier to induce experimental scrapie in hamsters and changed their pathogenic features. Virol J 9:63
28. Gao JM, Zhou XB, Xiao XL, Zhang J, Chen L, Gao C, Zhang BY, Dong XP (2006) Influence of guanidine on proteinase K resistance in vitro and infectivity of scrapie prion protein PrP (Sc). Acta Virol 50(1):25–32
29. Lund C, Olsen CM, Tveit H, Tranulis MA (2007) Characterization of the prion protein 3F4 epitope and its use as a molecular tag. J Neurosci Methods 165(2):183–190
30. Endres K, Mitteregger G, Kojro E, Kretzschmar H, Fahrenholz F (2009) Influence of ADAM10 on prion protein processing and scrapie infectiosity in vivo. Neurobiol Dis 36(2):233–241
31. Altmeppen HC, Prox J, Puig B, Kluth MA, Bernreuther C, Thurm D, Jorissen E, Petrowitz B, Bartsch U, De Strooper B, Saftig P, Glatzel M (2011) Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo. Mol Neurodegener 6:36
32. Marcello E, Saraceno C, Musardo S, Vara H, de la Fuente AG, Pelucchi S, Di Marino D, Borroni B, Tramontano A, Perez-Otano I, Padovani A, Giustetto M, Gardoni F, Di Luca M (2013) Endocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer’s disease. J Clin Invest 123(6):2523–2538
33. Marcello E, Gardoni F, Mauceri D, Romorini S, Jeromin A, Epis R, Borroni B, Cattabeni F, Sala C, Padovani A, Di Luca M (2007) Synapse-associated protein-97 mediates alpha-secretase ADAM10 trafficking and promotes its activity. J Neurosci 27(7):1682–1691
34. Anders A, Gilbert S, Garten W, Postina R, Fahrenholz F (2001) Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases. FASEB J 15(10):1837–1839
35. Van Wart HE, Birkedal-Hansen H (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci U S A 87(14):5578–5582
36. Grams F, Huber R, Kress LF, Moroder L, Bode W (1993) Activation of snake venom metalloproteinases by a cysteine switch-like mechanism. FEBS Lett 335(1):76–80
37. Laffont-Proust I, Faucheux BA, Hassig R, Sazdovitch V, Simon S, Grassi J, Hauw JJ, Moya KL, Haik S (2005) The N-terminal cleavage of cellular prion protein in the human brain. FEBS Lett 579(28):6333–6337
38. Cisse MA, Gandreuil C, Hernandez JF, Martinez J, Checler F, Vincent B (2006) Design and characterization of a novel cellular prion-derived quenched fluorimetric substrate of alpha-secretase. Biochem Biophys Res Commun 347(1):254–260
39. Xiang W, Windl O, Westner IM, Neumann M, Zerr I, Lederer RM, Kretzschmar HA (2005) Cerebral gene expression profiles in sporadic Creutzfeldt-Jakob disease. Ann Neurol 58(2):242–257
40. Tian C, Liu D, Sun QL, Chen C, Xu Y, Wang H, Xiang W, Kretzschmar HA, Li W, Shi Q, Gao C, Zhang J, Zhang BY, Han J, Dong XP (2013) Comparative analysis of gene expression profiles between cortex and thalamus in Chinese fatal familial insomnia patients. Mol Neurobiol. doi:10.1007/s12035-013-8426-6
41. Tian C, Liu D, Chen C, Xu Y, Gong HS, Shi Q, Zhang BY, Han J, Dong XP (2013) Global transcriptional profiling of the postmortem brain of a patient with G114V genetic Creutzfeldt-Jakob disease. Int J Mol Med 31(3):676–688
42. Chen C, Xiao D, Zhou W, Shi Q, Zhang HF, Zhang J, Tian C, Zhang JZ, Dong XP (2013) Global protein differential expression profiling of cerebrospinal fluid samples pooled from Chinese sporadic CJD and non-CJD Patients. Mol Neurobiol. doi:10.1007/s12035-013-8519-2
43. Liang J, Wang W, Sorensen D, Medina S, Ilchenko S, Kiselar J, Surewicz WK, Booth SA, Kong Q (2012) Cellular prion protein regulates its own alpha-cleavage through ADAM8 in skeletal muscle. J Biol Chem 287(20):16510–16520